Capital Brief on MSN
Neuren Pharmaceuticals' Daybue sales to reach $1b in 2028
Biotech company Neuren Pharmaceuticals has said projected global sales of its Rett syndrome treatment Daybue are set to reach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback